149 related articles for article (PubMed ID: 3349494)
21. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
Yang TB; Zeng FH; Sun ZQ
Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
[TBL] [Abstract][Full Text] [Related]
22. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.
Kassouf W; Swanson D; Kamat AM; Leibovici D; Siefker-Radtke A; Munsell MF; Grossman HB; Dinney CP
J Urol; 2006 Jun; 175(6):2058-62. PubMed ID: 16697803
[TBL] [Abstract][Full Text] [Related]
23. Analysis of 90 step-sectioned cystectomized specimens of bladder cancer.
Kakizoe T; Matsumoto K; Nishio Y; Kishi K
J Urol; 1984 Mar; 131(3):467-72. PubMed ID: 6699986
[TBL] [Abstract][Full Text] [Related]
24. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder.
May M; Nitzke T; Helke C; Vogler H; Hoschke B
Scand J Urol Nephrol; 2004; 38(3):231-5. PubMed ID: 15204377
[TBL] [Abstract][Full Text] [Related]
25. Urothelial (transitional cell) papilloma of the urinary bladder: a clinicopathologic study of 26 cases.
McKenney JK; Amin MB; Young RH
Mod Pathol; 2003 Jul; 16(7):623-9. PubMed ID: 12861056
[TBL] [Abstract][Full Text] [Related]
26. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
[TBL] [Abstract][Full Text] [Related]
27. [Clinical investigation of grade-up superficial bladder cancer].
Noguchi S; Kubota Y; Masuda M; Shuin T; Yao M; Hosaka M
Hinyokika Kiyo; 1995 Sep; 41(9):659-64. PubMed ID: 7484528
[TBL] [Abstract][Full Text] [Related]
28. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression.
King ED; Matteson J; Jacobs SC; Kyprianou N
J Urol; 1996 Jan; 155(1):316-20. PubMed ID: 7490878
[TBL] [Abstract][Full Text] [Related]
29. [Clinicopathological characteristics of micropapillary variant of urinary bladder carcinoma].
Radulović P; Pavić I; Marusić Z; Perić-Balja M; Znaor A; Kraus O; Kruslin B
Lijec Vjesn; 2008; 130(1-2):1-3. PubMed ID: 18589634
[TBL] [Abstract][Full Text] [Related]
30. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.
Cai T; Nesi G; Boddi V; Mazzoli S; Dal Canto M; Bartoletti R
Oncol Rep; 2006 Aug; 16(2):329-34. PubMed ID: 16820911
[TBL] [Abstract][Full Text] [Related]
31. [Clinical significance of multiple mucosal biopsies in new cases of superficial papillary bladder tumor].
Kanamaru H; Shirahase T; Moroi S; Taniguchi T; Kuo JY; Okuno H; Kihara Y; Arai Y
Hinyokika Kiyo; 1993 Feb; 39(2):127-30. PubMed ID: 8465685
[TBL] [Abstract][Full Text] [Related]
32. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M
Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389
[TBL] [Abstract][Full Text] [Related]
33. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.
Ro JY; Shen SS; Lee HI; Hong EK; Lee YH; Cho NH; Jung SJ; Choi YJ; Ayala AG
Am J Surg Pathol; 2008 May; 32(5):752-7. PubMed ID: 18379419
[TBL] [Abstract][Full Text] [Related]
34. Carcinoma in a bladder diverticulum: presentation and treatment outcome.
Golijanin D; Yossepowitch O; Beck SD; Sogani P; Dalbagni G
J Urol; 2003 Nov; 170(5):1761-4. PubMed ID: 14532771
[TBL] [Abstract][Full Text] [Related]
35. [Bladder preservation or initial cystectomy in T1G3 bladder cancer: which parameters help in therapeutic decision-making?].
Denzinger S; Burger M; Fritsche HM; Ganzer R; Blana A; Wieland WF; Otto W
Aktuelle Urol; 2008 Jan; 39(1):58-61; discussion 62-3. PubMed ID: 18228189
[TBL] [Abstract][Full Text] [Related]
36. [Clinical prognostic factors in superficial cancer of the urinary bladder].
Busto Catañón L; Sánchez Merino JM; Picallo Sánchez JA; Gelabert Mas A
Arch Esp Urol; 2001 Mar; 54(2):131-8. PubMed ID: 11341116
[TBL] [Abstract][Full Text] [Related]
37. [Clinical outcome of bladder preserving therapy for superficial high-grade bladder cancer].
Chiba K; Hirokawa M; Saito K; Urushibara M; Yumura Y; Saito K; Okada Y
Hinyokika Kiyo; 1997 May; 43(5):329-32. PubMed ID: 9208315
[TBL] [Abstract][Full Text] [Related]
38. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance.
Shen SS; Lerner SP; Muezzinoglu B; Truong LD; Amiel G; Wheeler TM
Hum Pathol; 2006 Jun; 37(6):726-34. PubMed ID: 16733214
[TBL] [Abstract][Full Text] [Related]
39. Low grade papillary transitional cell carcinoma pelvic recurrence masquerading as high grade invasive carcinoma, ten years after radical cystectomy.
Dangle PP; Wang WP; Mayerson J; Mortazavi A; Monk P
World J Surg Oncol; 2008 Sep; 6():103. PubMed ID: 18826578
[TBL] [Abstract][Full Text] [Related]
40. Superficial TCC bladder cancer: the impact of tumor differentiation on recurrence, progression and survival.
Kurth KH
Prog Clin Biol Res; 1984; 162A():307-18. PubMed ID: 6483914
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
